Biasing the lipoxin A4/formyl peptide receptor 2 pushes inflammatory resolution

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 45, 2013, Pages 18033-18034

  Filep, János G ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR 2; HOMODIMER; LEUKOTRIENE B4; LIPOCORTIN 1; LIPOXIN A; SERUM AMYLOID A; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFORMATIONAL TRANSITION; DIMERIZATION; HUMAN; IMMUNOPRECIPITATION; INFLAMMATION; MICROVASCULATURE; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; ANNEXIN A1; HUMANS; PROTEIN CONFORMATION; RECEPTORS, FORMYL PEPTIDE; SIGNAL TRANSDUCTION;

EID: 84887269420     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1317798110     Document Type: Note

References (20)

1. Serhan CN, Savill J (2005) Resolution of inflammation: The beginning programs the end. Nat Immunol 6(12):1191-1197.
2. Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349-361.
3. Nathan C, Ding A (2010) Nonresolving inflammation. Cell 140(6): 871-882.
4. Chiang N, et al. (2006) The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo. Pharmacol Rev 58(3):463-487.
5. Ye RD, et al. (2009) International Union of Basic and Clinical Pharmacology. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61(2):119-161.
6. Cooray SN, et al. (2013) Ligand-specific conformational change of the G-protein-coupled receptor ALX/FPR2 determines proresolving functional responses. Proc Natl Acad Sci USA 110:18232-18237.
7. El Kebir D, et al. (2007) Aspirin-triggered lipoxins override the apoptosisdelaying action of serum amyloid A in human neutrophils: A novel mechanism for resolution of inflammation. J Immunol 179(1):616-622.
8. Wan M, Godson C, Guiry PJ, Agerberth B, Haeggström JZ (2011) Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1. FASEB J 25(5):1697-1705.
9. Solito E, et al. (2003) A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J 17(11):1544-1546.
10. Perretti M, D'Acquisto F (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9(1):62-70.
11. Vago JP, et al. (2012) Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 92(2):249-258.
12. Lohse MJ (2010) Dimerization in GPCR mobility and signaling. Curr Opin Pharmacol 10(1):53-58.
13. Mary S, et al. (2012) Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor. Proc Natl Acad Sci USA 109(21):8304-8309.
14. Rossi AG, et al. (2006) Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12(9):1056-1064.
15. Brancaleone V, et al. (2011) Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature. J Immunol 186(8):4905-4914.
16. Bozinovski S, et al. (2012) Serum amyloid A opposes lipoxin to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 109(3):935-940.
17. El Kebir D, Gjorstrup P, Filep JG (2012) Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammation. Proc Natl Acad Sci USA 109(37): 14983-14988.
18. Damian M, Martin A, Mesnier D, Pin JP, Banères JL (2006) Asymmetric conformational changes in a GPCR dimer controlled by G-proteins. EMBO J 25(24):5693-5702.
19. Dalli J, et al. (2013) pro-resolving and tissue protective actions of annexin A1-based cleavage resistant peptides are mediated by FPR2/ALX. J Immunol 190:6478-6487.
20. Petasis NA, et al. (2008) Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties. Bioorg Med Chem Lett 18(4):1382-1387.